| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |